Cargando…
Changes to Drug-Coated Balloon Reimbursement Affect Peripheral Arterial Disease Patient Care: A Single-Center Experience
Introduction: Balloon angioplasty (BA) and stenting have long been the mainstays of endovascular therapy in peripheral arterial disease (PAD). However, the rise of drug-coated balloons (DCBs) has revolutionized care in recent years, with multiple clinical trials showing superiority over BA in mainta...
Autores principales: | Samia, Arthur M, Adams, George L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040687/ https://www.ncbi.nlm.nih.gov/pubmed/35495006 http://dx.doi.org/10.7759/cureus.23514 |
Ejemplares similares
-
Drug-coated balloons used in peripheral artery disease: experience
from a single center
por: Liu, Jinbo, et al.
Publicado: (2020) -
Does a Drug-Coated Balloon Accelerate Neoatherosclerosis?
por: Mori, Hiroyoshi, et al.
Publicado: (2020) -
Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020) -
Pushing the envelope: A drug-coated balloon for left main intervention
por: Uskela, Sanna, et al.
Publicado: (2022) -
Coronary-Pulmonary Artery Fistula Repair With Coil Embolization: A Single Center Experience
por: Sulemankhil, Imran, et al.
Publicado: (2022)